1-((4S)-2-(4-FLUORO-3,5-DIMETHYLPHENYL)-4,5,6,7-TETRAHYDRO-4-METHYL-2H-PYRAZOLO(4,3-C)PYRIDIN-3-YL)-1,3-DIHYDRO-2H-IMIDAZOL-2-ONE
UNII DZP9HR6QQ4
Substance Identification & Data
This profile provides standardized clinical and technical data for 1-((4s)-2-(4-fluoro-3,5-dimethylphenyl)-4,5,6,7-tetrahydro-4-methyl-2h-pyrazolo(4,3-c)pyridin-3-yl)-1,3-dihydro-2h-imidazol-2-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DZP9HR6QQ4.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2212021-62-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C18H20FN5O AVESCMIFCAVFIG-LBPRGKRZSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1-((4s)-2-(4-fluoro-3,5-dimethylphenyl)-4,5,6,7-tetrahydro-4-methyl-2h-pyrazolo(4,3-c)pyridin-3-yl)-1,3-dihydro-2h-imidazol-2-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.